Literature DB >> 26952772

Abnormal dose-response melatonin suppression by light in bipolar type I patients compared with healthy adult subjects.

Karen T Hallam1, Denovan P Begg1, James S Olver1, Trevor R Norman1.   

Abstract

OBJECTIVE: Among potential endophenotypes proposed for bipolar affective disorder focusing on circadian abnormalities associated with the illness has particularly high face validity. Melatonin sensitivity to light is one circadian endophenotype proposed as useful in bipolar disorder. The aim of this study was to investigate melatonin sensitivity to light over a range of light intensities in order to compare and contrast responses in bipolar I patients with those of healthy adult volunteers.
METHODS: The study included seven patients (4 females, 3 males) with bipolar I disorder and 34 control participants (22 females, 12 males) with no personal or family history of affective illness. Melatonin sensitivity to light was determined in all patients and participants across a range of light intensities (0, 200, 500 and 1000 lux).
RESULTS: The results indicated that patients showed melatonin super-sensitivity to light in comparison with controls, a response that was consistent across the entire light intensity range investigated.
CONCLUSION: The study provides further evidence for a super sensitive response in bipolar I patients and suggests that its potential usefulness as an endophenotypic marker of the illness is deserving of further research.

Entities:  

Year:  2009        PMID: 26952772     DOI: 10.1111/j.1601-5215.2009.00416.x

Source DB:  PubMed          Journal:  Acta Neuropsychiatr        ISSN: 0924-2708            Impact factor:   3.403


  8 in total

1.  The SSRI citalopram increases the sensitivity of the human circadian system to light in an acute dose.

Authors:  E M McGlashan; L S Nandam; P Vidafar; D R Mansfield; S M W Rajaratnam; S W Cain
Journal:  Psychopharmacology (Berl)       Date:  2018-09-15       Impact factor: 4.530

2.  Hypnotic and Melatonin/Melatonin-Receptor Agonist Treatment in Bipolar Disorder: A Systematic Review and Meta-Analysis.

Authors:  Niall M McGowan; David S Kim; Marta de Andres Crespo; Lampros Bisdounis; Simon D Kyle; Kate E A Saunders
Journal:  CNS Drugs       Date:  2022-03-19       Impact factor: 5.749

3.  Melatonin suppression by melanopsin-weighted light in patients with bipolar I disorder compared to healthy controls

Authors:  Philipp Ritter; Falk Wieland; Debra J. Skene; Andrea Pfennig; Maria Weiss; Michael Bauer; Emanuel Severus; Henry Güldner; Cathrin Sauer; Bettina Soltmann; Stefanie Neumann
Journal:  J Psychiatry Neurosci       Date:  2020-03-01       Impact factor: 6.186

4.  The characteristics of sleep in patients with manifest bipolar disorder, subjects at high risk of developing the disease and healthy controls.

Authors:  Philipp S Ritter; Carolin Marx; Natalia Lewtschenko; Steffi Pfeiffer; Karolina Leopold; Michael Bauer; Andrea Pfennig
Journal:  J Neural Transm (Vienna)       Date:  2012-08-18       Impact factor: 3.575

5.  High sensitivity and interindividual variability in the response of the human circadian system to evening light.

Authors:  Andrew J K Phillips; Parisa Vidafar; Angus C Burns; Elise M McGlashan; Clare Anderson; Shantha M W Rajaratnam; Steven W Lockley; Sean W Cain
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-28       Impact factor: 11.205

6.  Sleep disturbances in the context of neurohormonal dysregulation in patients with bipolar disorder.

Authors:  Tom Roloff; Ida Haussleiter; Klara Meister; Georg Juckel
Journal:  Int J Bipolar Disord       Date:  2022-03-01

Review 7.  Neurobiological and behavioral mechanisms of circadian rhythm disruption in bipolar disorder: A critical multi-disciplinary literature review and agenda for future research from the ISBD task force on chronobiology.

Authors:  Michael J McCarthy; John F Gottlieb; Robert Gonzalez; Colleen A McClung; Lauren B Alloy; Sean Cain; Davide Dulcis; Bruno Etain; Benicio N Frey; Corrado Garbazza; Kyle D Ketchesin; Dominic Landgraf; Heon-Jeong Lee; Cynthia Marie-Claire; Robin Nusslock; Alessandra Porcu; Richard Porter; Philipp Ritter; Jan Scott; Daniel Smith; Holly A Swartz; Greg Murray
Journal:  Bipolar Disord       Date:  2021-12-10       Impact factor: 5.345

Review 8.  The Management of Prodromal Symptoms of Bipolar Disorder: Available Options and Future Perspectives.

Authors:  Elisa Del Favero; Cristiana Montemagni; Paola Bozzatello; Claudio Brasso; Cecilia Riccardi; Paola Rocca
Journal:  Medicina (Kaunas)       Date:  2021-05-28       Impact factor: 2.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.